Interaction of KAI1 on tumor cells with DARC on vascular endothelium leads to metastasis suppression

Nature Medicine

Volumn 12, Issue 8, 2006, Pages 933-938

  Bandyopadhyay, Sucharita ^a   Zhan, Rui ^a   Chaudhuri, Asok ^b   Watabe, Misako ^a   Pai, Sudha K ^a   Hirota, Shigeru ^c   Hosobe, Sadahiro ^c   Tsukada, Taisei ^c   Miura, Kunio ^c   Takano, Yukio ^c   Saito, Ken ^c   Pauza, Mary E ^a   Hayashi, Sunao ^a   Wang, Ying ^a   Mohinta, Sonia ^a   Mashimo, Tomoyuki ^a   Iiizumi, Megumi ^a   Furuta, Eiji ^a   Watabe, Kounosuke ^a  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NEW YORK BLOOD CENTER   (United States)

^c AKITA RED CROSS HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD82 ANTIGEN; CELL SURFACE MARKER; CELL SURFACE PROTEIN; PROTEIN DARC; PROTEIN P21; PROTEIN TBX2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GROWTH; CELL PROLIFERATION; CHROMOSOME 11P; CONTROLLED STUDY; GENE CONTROL; HUMAN; HUMAN CELL; KAI1 GENE; KNOCKOUT MOUSE; LUNG METASTASIS; METASTASIS; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; RAT; SUPPRESSOR GENE; VASCULAR ENDOTHELIUM;

ALLELES; AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; BREAST NEOPLASMS; CELL AGING; CELL LINE, TUMOR; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DUFFY BLOOD-GROUP SYSTEM; ENDOTHELIUM, VASCULAR; FEMALE; HETEROZYGOTE; HUMANS; KANGAI-1 PROTEIN; LUNG NEOPLASMS; MALE; MEMBRANE GLYCOPROTEINS; MICE; MICE, KNOCKOUT; MOLECULAR SEQUENCE DATA; NEOPLASM METASTASIS; PROSTATIC NEOPLASMS; PROTEIN ISOFORMS; PROTEIN STRUCTURE, TERTIARY; RATS; RECEPTORS, CELL SURFACE; T-BOX DOMAIN PROTEINS;

ANIMALIA;

EID: 33746791465     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm1444     Document Type: Article

References (22)

1. Dong, J.T. et al. KAI1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2. Science 268, 884-886 (1995).
2. Fukudome, K. et al. Identification of membrane antigen C33 recognized by monoclonal antibodies inhibitory to human T-cell leukemia virus type 1 (HTLV-1)-induced syncytium formation: altered glycosylation of C33 antigen in HTLV-1-positive T cells. J. Virol. 66, 1394-1401 (1992).
3. Yoshida, B.A., Sokoloff, M.M. & Welch, D.R. Rinker-Schaeffer, C.W. Metastasis-suppressor genes: a review and perspective on an emerging field. J. Natl. Cancer Inst. 92, 1717-1730 (2000).
4. Fields, S. & Song, O. A novel genetic system to detect protein-protein interactions. Nature 340, 245-246 (1989).
5. Chaudhuri, A. et al. Detection of Duffy antigen in the plasma membranes and caveolae of vascular endothelial and epithelial cells of nonerythroid organs. Blood 89, 701-712 (1997).
6. Miller, L.H., Mason, S.J., Dvorak, J.A., McGinnis, M.H. & Rothman, I.K. Erythrocyte receptors for (Plasmodium knowlesi) malaria: Duffy blood group determinants. Science 189, 561-563 (1975).
7. Horuk, R. et al. A receptor for the malarial parasite Plasmodium vivax: the erythrocyte chemokine receptor. Science 261, 1182-1184 (1993).
8. Hadley, T.J. et al. Postcapillary venule endothelial cells in kidney express a multispecific chemokine receptor that is structurally and functionally identical to the erythroid isoform, which is the Duffy blood group antigen. J. Clin. Invest. 94, 985-991 (1994).
9. Iwamoto, S., Omi, T., Kajii, E. & Ikemoto, S. Genomic organization of the glycoprotein D gene: Duffy blood group Fya/Fyb alloantigen system is associated with a polymorphism at the 44-amino acid residue. Blood 85, 622-626 (1995).
10. Al-Mehdi, A.B. et al. Intravascular origin of metastasis from the proliferation of endothelium-attached tumor cells: a new model for metastasis. Nat. Med. 6, 100-102 (2000).
11. Lebel-Binay, S., Lagaudriere, C., Fradelizi, D. & Conjeaud, H. CD82, member of the tetra-span-transmembrane protein family, is a costimulatory protein for T cell activation. J. Immunol. 155, 101-110 (1995).
12. Sigala, S. et al. Suppression of telomerase, reexpression of KAI1, and abrogation of tumorigenicity by nerve growth factor in prostate cancer cell lines. Clin. Cancer Res. 5, 1211-1218 (1999).
13. Luo, H., Chaudhuri, A., Zbrzezna, V., He, Y. & Pogo, A.O. Deletion of the murine Duffy gene (Dfy) reveals that the Duffy receptor is functionally redundant. Mol. Cell. Biol. 20, 3097-3101 (2000).
14. Chen, Z. et al. Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis. Nature 436, 725-730 (2005).
15. Michaloglou, C. et al. BRAFE600-associated senescence-like cell cycle arrest of human naevi. Nature 436, 720-724 (2005).
16. Braig, M. et al. Oncogene-induced senescence as an initial barrier in lymphoma development. Nature 436, 660-665 (2005).
17. Varela, I. et al. Accelerated ageing in mice deficient in Zmpste24 protease is linked to p53 signalling activation. Nature 437, 564-568 (2005).
18. Schwarze, S.R., Fu, V.X., Desotelle, J.A., Kenowski, M.L. & Jarrard, D.F. The identification of senescence-specific genes during the induction of senescence in prostate cancer cells. Neoplasia 7, 816-823 (2005).
19. Prince, S., Carreira, S., Vance, K.W., Abrahams, A. & Goding, C.R. Tbx2 directly represses the expression of the p21(WAF1) cyclin-dependent kinase inhibitor. Cancer Res. 64, 1669-1674 (2004).
20. Mannion, B.A., Berditchevski, F., Kraeft, S.K., Chen, L.B. & Hemler, M.E. Transmembrane-4 superfamily proteins CD81 (TAPA-1), CD82, CD63, and CD53 specifically associated with integrin alpha 4 beta 1 (CD49d/CD29). J. Immunol. 157, 2039-2047 (1996).
21. Orr, F.W., Wang, H.H., Lafrenie, R.M., Scherbarth, S. & Nance, D.M. Interactions between cancer cells and the endothelium in metastasis. J. Pathol. 190, 310-329 (2000).
22. Ausubel, F. et al. Yeast vectors and assays for expression of cloned genes. in Current Protocols in Molecular Biology Ch 13, 13.6.1 (John Wiley & Sons, Inc., New York, 2004).